Our Board of Directors are charged with promoting and ensuring good corporate governance for ITL and its controlled entities and divisions. The Board seeks to uphold the highest ethical and professional standards and ensure responsible corporate conduct on behalf of the Company’s staff, shareholders and other stakeholders.
Our BOD Philosophy
- Lay solid foundations for management and oversight
- Structure the Board to add value
- Promote ethical and responsible decision making
- Safeguard integrity in financial reporting
- Make timely and balanced disclosure
- Respect the rights of shareholders
- Recognise and manage risk
- Remunerate fairly and responsibly
- Diversity Policy
Bill Mobbs, Non-Executive Chairman
Bill Mobbs is an entrepreneur with a passion for innovation and technology. Over his 30 plus years of experience in Healthcare and technology he has won numerous awards and has authored over 20 families of patents.
Bill is the Executive Chairman and Founder of ITL Limited, an ASX listed global medical device company. He was also Executive Chairman and Founder of MyHealthTest Pty. Ltd. (prior to acquisition by ITL) a specialized laboratory testing company, and Targeted Genomics Pty. Ltd. a specialised Genomic testing company both of which are privately held companies. Bill is also a Director of not-for-profit organizations Hospital IP, with branches in Australian Capital Territory (ACT), New South Wales (NSW) and Queensland (QLD) Australia.
Some of his previous roles include, Chairman of London AIM listed technology Company Seeing Machines Limited and Admin Bandit Pty. Ltd., Director of Connexxion Pty. Ltd. And an industry representative to the Therapeutics Goods Administration (TGA).
Anthony Hanrahan, Director (Non-Executive)
Appointed effective 5/03/2025
Stephen Winslade, Director (Non-Executive)
Appointed effective 5/03/2025
